Your browser doesn't support javascript.
loading
Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine.
Kim, Tae Hwan; Shin, Soyoung; Kim, Sarah; Bulitta, Jürgen B; Weon, Kwon-Yeon; Joo, Sang Hoon; Ma, Eunsook; Yoo, Sun Dong; Park, Gi-Young; Kwon, Dong Rak; Jeong, Seok Won; Lee, Da Young; Shin, Beom Soo.
Afiliação
  • Kim TH; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA. taehwan.kim@cop.ufl.edu.
  • Shin S; College of Pharmacy, Wonkwang University, Iksan, Jeonbuk 54538, Korea. shins@wku.ac.kr.
  • Kim S; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA. sarahkim@cop.ufl.edu.
  • Bulitta JB; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA. JBulitta@cop.ufl.edu.
  • Weon KY; College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 38430, Korea. weonky@cu.ac.kr.
  • Joo SH; College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 38430, Korea. sjoo@cu.ac.kr.
  • Ma E; College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 38430, Korea. masook@cu.ac.kr.
  • Yoo SD; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Korea. sdyoo@skku.ac.kr.
  • Park GY; Department of Rehabilitation Medicine, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea. parkgy@cu.ac.kr.
  • Kwon DR; Department of Rehabilitation Medicine, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea. coolkwon@cu.ac.kr.
  • Jeong SW; College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 38430, Korea. jswpia@gmail.com.
  • Lee DY; College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongbuk 38430, Korea. dayoung0717@gmail.com.
  • Shin BS; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Korea. bsshin@skku.edu.
Molecules ; 22(9)2017 Sep 10.
Article em En | MEDLINE | ID: mdl-28891960

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Substâncias Protetoras / Desoxicitidina / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Substâncias Protetoras / Desoxicitidina / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos